A Buffalo-based company is poised to research threats posed by biological weapons and medication-resistant infections on behalf of the federal government. The contract could be worth nearly $70 million dollars.
The job of the Department of Health and Human Services is to fill the gaps in the government’s response to possible medical scenarios. That’s the basis behind a grant awarded to Buffalo’s CUBRC, which will fund research that could prove invaluable in the case of an outbreak and biological attack, says CUBRC’s Anne Radcliff ”What it will mean for most people in the world is potential cures for diseases that are currently incurable.”
Read more at Innovationtrail.org.